Description
Product Overview / 商品概要
Delgocitinib Ointment 0.5% (コレクチム軟膏0.5%)
Generic: Delgocitinib / デルゴシチニブ
Therapeutic Category: External Janus Kinase (JAK) Inhibitor / 外用ヤヌスキナーゼ(JAK)阻害剤
Manufactured by: Shionogi & Co., Ltd. / 塩野義製薬株式会社
Composition & Specification / 組成・規格
Active Ingredient: Delgocitinib 5mg per 1g / 1g中 デルゴシチニブ5mg
Additives: White Petrolatum, Paraffin, Squalane / 白色ワセリン、パラフィン、スクワラン
Appearance: White ointment
外観: 白色の軟膏
Indications / 効能効果
EN: Atopic dermatitis
JA: アトピー性皮膚炎
Dosage and Administration / 用法用量
EN: For adults, usually apply an appropriate amount of 0.5% ointment to the affected area twice daily. The application amount per dose should not exceed 5g.
JA: 通常、成人には、0.5%製剤を1日2回、適量を患部に塗布する。なお、1回あたりの塗布量は5gまでとする。
Contraindications / 禁忌
EN: Patients with a history of hypersensitivity to any component of this drug
JA: 本剤の成分に対し過敏症の既往歴のある患者
Regulatory Information / 規制情報
Approval No.: 30200AMX00046000
Sales Started: June 2020 / 2020年6月
Classification Code: 872699
Storage: Store at room temperature / 室温保存
Shelf Life: 36 months / 36箇月
Packaging / 包装
Main Package (for sale): 5g x 10 tubes / 5g×10本
Other Available Packages (by special order): 5g x 10 tubes, 10g x 10 tubes
Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.



![Ofloxacin Otic Solution 0.3% [CEO] (Ofloxacin Otic Solution CEO® / オフロキサシン耳科用液0.3%「CEO」)](https://jp-pharma.com/wp-content/uploads/2026/06/OFL-03-OTC_1200x1200-324x324.jpg)
Reviews
There are no reviews yet.